Neurokinin receptor antagonist, fezolinetant, for treatment of menopausal vasomotor symptoms. Pinkerton JV, Redick DL, Homewood LN, Kaunitz AM, et al. J Clin Endocrinol Metab 2023 Apr 25:dgad209. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Pinkerton JV, Redick DL, Homewood LN, Kaunitz AM, et al. Neurokinin receptor antagonist, fezolinetant, for treatment of menopausal vasomotor symptoms. J Clin Endocrinol Metab 2023 Apr 25:dgad209. doi: 10.1210.
PMID: 37097747